Cabozantinib and Dostarlimab in Recurrent Gynecologic Carcinosarcoma
University of Alabama at Birmingham
University of Alabama at Birmingham
AstraZeneca
PinkDx, Inc.
AstraZeneca
Genmab
Imperial College London
Northwestern University
M.D. Anderson Cancer Center
Abramson Cancer Center at Penn Medicine
Pfizer
Duke University
Dana-Farber Cancer Institute
University of Miami
Queensland Centre for Gynaecological Cancer
DL Analytics